MAP2K7 and familial atrioventricular septal defect: In recent years, almost 54%-57.5% of patients with ECD have been reported to carry BRAFV600E-activating mutations in the RAS-RAF-MEK-extracellular signal-regulated kinase signaling pathway (1, 17).